funding to further develop a prophylactic vaccine based on its proprietary outer membrane vesicles (OMV) platform technology. Called NGoXIM, the vaccine is based on gonococcal OMVs combined with ...
Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback